| Trial ID: | L1425 |
| Source ID: | NCT01464320
|
| Associated Drug: |
Abt-614
|
| Title: |
A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
|
| Interventions: |
DRUG: ABT-614|DRUG: Placebo Comparator
|
| Outcome Measures: |
Primary: Change in drug concentration, Blood and urine tests, Day -1 (Baseline) and up to Day 15|Change in glomerular filtration rate, Blood and urine tests, Day -1 (Baseline) and up to Day 15 | Secondary: Change in urinary albumin excretion, Urine tests, Day -1 (Baseline) and up to Day 15
|
| Sponsor/Collaborators: |
Sponsor: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-11
|
| Completion Date: |
2012-04
|
| Results First Posted: |
|
| Last Update Posted: |
2012-08-22
|
| Locations: |
Site Reference ID/Investigator# 63442, Miami, Florida, 33136, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01464320
|
